5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability

@inproceedings{Navez20155LM,
  title={5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability},
  author={Marie Louise Navez and Christopher Monella and Irmgard Boesl and Daniela Sommer and Claire Delorme},
  booktitle={Pain and therapy},
  year={2015}
}
Postherpetic neuralgia (PHN) is a common, very painful, and often long-lasting complication of herpes zoster which is frequently underdiagnosed and undertreated. It mainly affects the elderly, many of whom are already treated for comorbidities with a variety of systemic medications and are thus at high risk of drug-drug interactions. An efficacious and safe treatment with a low interaction potential is therefore of high importance. This review focuses on the safety and tolerability of the 5… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Abstract 170 of the 8th Congress of the European Federation of IASP Chapters (EFIC), 9–12 October 2013, Florence

  • J O’Hara, M Obradovic, H Liedgens, compliance et al. Relationship between, In patient reported outcomes in post herpetic neuralg use.
  • European Pain Federation EFIC; 2013. 14 Pain…
  • 2015

implications for neuroimaging

  • DA Seminowicz, Davis KD. A re-examination of pain-cognition interactions
  • Pain. 2007;130:8–13. Pain Ther
  • 2015
1 Excerpt

More than 20 million patients used 5 % lidocaine medicated plaster : an update on its safety profile

  • I Boesl, S Koenig
  • PainWeek
  • 2014

Similar Papers

Loading similar papers…